While VOL.U.LIFT was developed in response to the unique skin changes associated with GLP-1 medications (facial volume loss, sagging, crepey texture), it is formulated for anyone experiencing these concerns including those caused by natural aging, weight loss, perimenopause, or loss of skin elasticity
Sumithran P, Prendergast LA, Delbridge E, Purcell K, Shulkes A, Kriketos A, Proietto J
Role of specialized clinics Clinics for LOE, as implemented in the United States, provide multidisciplinary care for older adults with new-onset seizures
Retatrutide has produced more weight loss in trials (~28% versus survodutides ~15 to 19%), while survodutide has stood out for a different reason: unusually strong results in fatty liver disease
However, the FDA does not evaluate dietary supplement claims for effectiveness
The court has scheduled key hearings for May 2025 regarding expert testimony